0000896262-20-000035.txt : 20201202 0000896262-20-000035.hdr.sgml : 20201202 20201202164644 ACCESSION NUMBER: 0000896262-20-000035 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201130 FILED AS OF DATE: 20201202 DATE AS OF CHANGE: 20201202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ginn Scott G CENTRAL INDEX KEY: 0001543701 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 201364350 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 4 1 wf-form4_160694559096896.xml FORM 4 X0306 4 2020-11-30 0 0000896262 AMEDISYS INC AMED 0001543701 Ginn Scott G 3854 AMERICAN WAY, SUITE A BATON ROUGE LA 70816 0 1 0 0 Chief Financial Officer Common Stock 2020-11-30 4 M 0 975 27.35 A 18824 D Common Stock 2020-11-30 4 S 0 975 241.62 D 17849 D Common Stock 2714 I Through 401(k) Plan Stock Option (Right to Buy) 27.35 2020-11-30 4 M 0 975 0 D 2025-05-01 Common Stock 975.0 225 D The total amount of shares beneficially owned includes 887 shares held in an employee stock purchase plan account. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. The information in this report is based on a plan statement dated as of September 30, 2020. On May 1, 2015, the reporting person was granted an option to purchase 22,500 shares of common stock. The option vested based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2017 were met, resulting in vesting of the option as to 5,625 shares (the "2017 Tranche Options"), subject to additional time-based vesting as follows: one-third of the 2017 Tranche Options vested on May 1, 2018, one-third of the 2017 Tranche Options vested on May 1, 2019 and one-third of the 2017 Tranche Options vested on May 1, 2020. After the transactions reported in this Form 4, 225 of the options remain unexercised. /s/ Jennifer R. Guckert, pursuant to a power of attorney 2020-12-02